hospital than patients admitted for any reason. Specific disorders associated with a high demand on hospital services included cystic fibrosis, Down syndrome, osteogenesis imperfecta, thalassemia, and von Willebrand's disease. Conclusions: Children and adolescents with single gene and chromosomal disorders placed higher demands on hospital services than other patients in their age group, but were responsible for a relatively small proportion of hospital admissions and costs. These data will enable informed planning of health care services for patients with single gene and chromosomal disorders in Western Australia.
Introduction
The twentieth century saw a major shift in the profile of human health and disease from communicable to non-communicable and genetic disease, due largely to the successful introduction of antibiotic therapy and vaccination programs for infectious diseases [1, 2] . This is illustrated by data from the Great Ormond Street Hospital for Children in London, where the proportion of childhood deaths attributed to genetic disorders increased from 16 .5% in 1914 to 37.5% in 1954 [3] . Similar transitions occurred in all industrialized nations and the increasing burden of genetic disease, especially in childhood, has been recognized as an area of concern since the 1970's [4] .
Genetic disorders can be divided into 3 categories: those caused primarily by changes in a single gene, chromosomal abnormalities, and those resulting from interactions between multiple genes and the environment (complex disorders). Although single gene and chromosomal disorders are individually rare, together they affect approximately 2% of the population, with estimates suggesting an incidence of 3.8 per 1,000 for chromosomal disorders and 20 per 1,000 for single gene disorders [5] .
Previous studies investigating the impact of genetic disease on hospital admissions found that patients with genetic conditions had more admissions, longer hospital stays and increased morbidity and mortality than patients without genetic conditions ( table 1 ) [2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The landmark study in this area was published by Hall et al. [4] who reported that of all admissions in a pediatric hospital, 4.5% were due to clearly genetic disorders (single gene or chromosomal), 48.9% to partly genetic conditions and 46.6% to non-genetic conditions. Patients with clearly genetic disorders had a higher mean number of admissions and stayed longer in hospital than patients without a genetic disorder [4] . More recent hospital-based studies have explored the impact of genetic disease on different types of hospital admissions, including those to emergency departments [12] , intensive care/high risk units [8] and general hospital wards [11, 15] . Interestingly, most report similar data, regardless of the setting, with the proportion of childhood and adolescent admissions due to single gene or chromosomal disorders ranging from 5.0-11.1% ( table 1 ) . A population-based study of hospital admissions of people aged less than 20 years also reported similar data, with 12% of admissions in California and 9% in South Carolina due to genetic diseases and birth defects [16] . Admissions due to genetic diseases and birth defects were found to be longer and cost twice as much as those from other causes [16] .
The current study assessed the admission patterns of children and adolescents with single gene and chromosomal disorders using the population-based hospital services data available in Western Australia (WA). We chose to focus on single gene and chromosomal disorders, rather than all 'genetic diseases', as the distinction between genetic and non-genetic conditions has become ill defined in recent years, with evidence that even infectious disease has a genetic component [17, 18] . Single gene and chromosomal disorders are easier to define, may be se- [20] . The WADLS is a multi-set system used for the creation, storage, update, and retrieval of links between health and welfare-related data and contains health data for the historical population of recent decades (3.7 million individuals going back as far as 1966) [20] .
The aims of this study were to (a) investigate the impact of single gene and chromosomal disorders on the frequency and duration of hospital admissions in childhood and adolescence, with a view to informing health care service planning, (b) assess the capability of the existing WA data linkage system to adequately reflect the impact of patients with single gene and chromosomal disorders on the hospital system, and (c) explore whether the impact of these disorders in WA is similar to that described in other populations.
Methods
For this study, 296 diagnosis codes specific to single gene and chromosomal disorders were identified from the International Statistical Classification of Diseases, Tenth Revision, Australian Modification (ICD-10-AM; ICD-10) [21] (online suppl. table 1, www.karger.com/doi/10.1159/000321767). The ICD-10-AM differs from the ICD-10 in that it includes some Australian extensions and Australian-specific disease codes. The majority of ICD-10-AM diagnosis codes used in this study were identical to ICD-10 codes, except for some multi-system syndromes, which resulted in the ICD-10-AM code being mapped to the code immediately above it in the hierarchy of both classifications. Data in this study were grouped and analyzed using higher-level hierarchy classifications and as such can be compared to other studies using ICD-10.
The WA Hospital Morbidity Data System was searched electronically for any individual aged 0-19 years who had at least one of the selected ICD-10-AM codes recorded in the diagnosis fields between 2000 and 2006. For each of these individuals, all of their linked records between 2000 and 2006 were also extracted. The data extracted for each patient included the number of admissions for the principal diagnosis, the number of all admissions, the number of same-day admissions versus overnight admissions, the mean length of stay (LOS) of overnight admissions, and the cost of all admissions for a person with a specific diagnosis.
Costs in Australian dollars (AUD) were calculated by applying Commonwealth Department of Health and Ageing year-specific average cost-weights to the Australian Refined Diagnosis-Related Group (AR-DRG) of the admission [22] . Diagnosis Related Groups (DRGs) are a patient classification scheme that relates the number and types of patients treated in a hospital to the resources required by that hospital. Each hospital separation is assigned a DRG and each DRG represents a class of patients with similar clinical conditions requiring similar hospital services. Cost-weights are allocated to DRGs on the basis of the National Hospital Data Collection, which includes hospital cost and activity data for a given financial year. Costs for 2000-2006 were adjusted to the reference year 2006-2007 using total health price index deflators [23] and converted from Australian to US dollars using the mean exchange rate for the 2006-2007 financial year, obtained from www.oanda. com.
Statistics describing the total number of patients, total admissions, mean LOS, and cost of admissions for patients admitted for any reason between 2000 and 2006 were also extracted from the WA Hospital Morbidity Data System, and costs were calculated as for the cases.
The genetic data were examined both by type of disorder and by age group. One-year data sets were used to investigate admissions by age group to confine each patient to a single age group. The 1-year data sets were then compared to all admissions in WA in that year. The age groups used were: ! 1 year (infancy), 2-4 years (early childhood), 5-9 years (middle childhood), 10-14 years (late childhood/early adolescence), and 15-19 years (late adolescence). These 5-year age groupings are commonly used in health statistics and allowed comparison of our data to publicly available health and hospital data. The ! 1 and 2-4 year age groups aimed to capture admissions during infancy versus young childhood, as it was hypothesized that combining these age groups may lead to oversimplification and loss of data.
The Department of Health of Western Australia Human Research Ethics Committee approved the use of the WA Hospital Morbidity Data collection for this study (project number 200723).
Results
In total, 3,271 different patients aged 0-19 years with a single gene or chromosomal disorder were admitted to hospital in Western Australia between 2000 and 2006 ( table 2 ). These patients accounted for 14,197 admissions. Metabolic disorders, chromosomal abnormalities, diseases of the blood and blood-forming organs, neuromuscular disorders, and skeletal disorders had the highest number of patients, admissions and highest costs, while diseases of the circulatory and digestive systems affected very few patients.
Patients admitted to hospital with single gene or chromosomal disorders were also analyzed by age group and the data compared to all patients admitted to hospital in The ratio of same day to overnight admissions varied with age group but was similar for patients with single gene or chromosomal disorders versus all patients, except in the 15-19 year age group where 70% of genetic admissions were for at least 1 night, compared to 51% of all admissions ( tables 3 and 4 ). There was also some variation in the proportion of same day versus overnight admissions depending on the type of genetic disorder. For example, 74% of patients with immune disorders were admitted and discharged on the same day, com- pared to only 25% of patients with endocrine disorders and 21% of patients with disorders of the urinary system ( table 2 ) .
Patients with single gene and chromosomal disorders had a higher number of admissions per patient and a longer mean LOS compared to other patients, and this was consistent over all age groups ( tables 3 and 4 ). Correspondingly, the cost per patient and cost per admission were higher for patients with single gene and chromosomal disorders than for other patients ( tables 3 , 4 and 5 ). Interestingly, the proportion of overall patients, admissions and costs in each age groups differed between patients with single gene and chromosomal disorders and other patients, which may indicate differences in the disease and resource profile at different ages between the 2 groups. Overall, patients with single gene and chromosomal disorders accounted for 5.1% of the cost of hospital admissions of 0-19 year olds in WA in 2006 ( table 5 ) ( table 2 ) .
We next examined which specific single gene and chromosomal disorders contributed most to hospital admissions and costs in WA from [2000] [2001] [2002] [2003] [2004] [2005] [2006] ( table 6 ) . Cystic fibrosis (CF) and Down syndrome (DS) were each responsible for 12% of admissions and accounted for 22% and 12% of the overall costs of hospital admissions of patients with single gene or chromosomal disorders. CF accounted for 68% of the costs associated with metabolic disorders and DS for 57% of those attributed to chromosomal abnormalities (shown in table 1 ). The next most costly patients were those with congenital malformations (e.g. Noonan syndrome and Marfan's syndrome), osteogenesis imperfecta (OI) and von Willebrand's disease (vWD), which each accounted for approximately 4% of the costs associated with patients with single gene and chromosomal disorders.
The admission costs for patients with these disorders were also analyzed by age at admission ( table 6 ). The total cost of admissions associated with DS, polydactyly and spinal muscular atrophy were highest in patients less than one year of age, with a steady decline in expenditure in the older age groups. In contrast, the total costs due to CF, vWD and primary disorders of muscle (e.g. Duchenne muscular dystrophy and congenital muscular dystrophy) increased between the ages of 5-19 years. Other conditions, such as metabolic mitochondrial disorders, showed a peak in costs in early childhood, while the osteochondrodysplasias (e.g. OI) were associated with high admission costs from the ages of 1-14 years, and a decline thereafter. Changes in costs between age groups were due to either a change in the number of admissions or the cost per admission. 
Discussion

Impact of Single Gene and Chromosomal Disorders on Hospital Admissions
Overall, 1.5% of patients aged 0-19 years admitted to hospital in WA in 2006 had a single gene or chromosomal disorder and these patients accounted for 2.6% of admissions and 5.1% of total hospital costs. When hospital admissions were investigated over a 7-year period (2000) (2001) (2002) (2003) (2004) (2005) (2006) , genetic conditions accounted for 3.1% of admissions and 4.3% of total costs. These data suggest that hospital admissions in WA due to single gene or chromosomal disorders in children and adolescents were relatively stable during this time. Patients with single gene and chromosomal disorders had more admissions to hospital and a greater mean LOS than patients admitted for any reason in WA in 2006, leading to higher per-admission and per-patient costs. These data are consistent with other studies ( table 1 ) [4, 8, 11, 16] , despite differences in the population surveyed, data collection procedures and ICD coding used.
Patients with CF and DS accounted for the highest number of admissions (12% each) and highest costs (22% and 12% respectively) of patients with single gene and chromosomal disorders, which is also consistent with previously published data [4, 11] . Hall et al. [4] found that CF and DS were the most common clearly genetic disorders in their cohort while McCandless et al. [11] reported that 11% of admissions for single gene and chromosomal disorders were due to CF and 12% to chromosomal disorders. Taken together, these data suggest that in populations of primarily Caucasian heritage, CF and DS are responsible for a significant proportion of hospital admissions due to single gene and chromosomal disorders and this has remained constant over at least a 30-year period.
We also examined whether the impact of the most costly single gene and chromosomal disorders changed during childhood and adolescence ( table 6 ) . CF and primary disorders of muscle (e.g. Duchenne muscular dystrophy) were associated with an increased number of admissions and associated costs as patients became older. These data are consistent with other studies [24, 25] and with the natural history of these disorders, which have a greater impact on morbidity with increasing age [26] . In contrast, admissions due to DS and polydactyly show a decreasing trend in admissions in older children and adolescents, also consistent with the course and management of these disorders [27, 28] .
Our study also examined all genetic admissions to hospital in 5 different age groups ( table 3 ) . Yoon et al. [16] found the mean cost of admissions and the proportion of total hospital costs due to genetic diseases and birth defects was highest in infants aged ! 1 year and decreased throughout childhood and adolescence whereas we found that the proportion of total WA hospital admissions and costs due to patients with single gene and chromosomal disorders was highest in the 1-4 year age group and declined thereafter ( table 5 ) . However, Yoon et al. [16] included all birth defects (which are often diagnosed in the first year of life) whereas we limited birth defects to those known to be of single gene or chromosomal origin. Interestingly, although the proportion of total admissions and costs due to patients with single gene and chromosomal conditions decrease in late adolescence (15-19 years) , the actual cost per admission and cost per patient in this age group is higher, relative to all patients, than in any other age group (2.6 fold and 5.2 fold, respectively) (compare table 3 and 4 ). Thus, although less patients with single gene and chromosomal disorders are admitted to hospital in this older age group, those patients that are admitted place high demands on the hospital system.
To ascertain whether the decreasing number of admissions of patients with single gene and chromosomal disorders with increasing age could be explained by the death of severely affected individuals, we also investigated the death data for the patients who had selected ICD-10 codes recorded in the diagnosis field. Thirteen deaths were recorded in patients aged 0-19 years, 4 in infants less than 1 year. Thus, although patient death would be a contributing factor leading to a decreased number of hospitalizations with increasing age, this low number of deaths is unlikely to have had a major influence on our dataset.
Methodology and Limitations
The fact that the pattern and costs of hospital admissions of specific single gene and chromosomal disorders is consistent with other studies and the known clinical presentation of these diseases suggests that the WA hospital morbidity database is an appropriate tool to measure the impact of patients with single gene and chromosomal disorders on the hospital system in WA.
Overall, however, the proportion of admissions due to patients with single gene and chromosomal disorders in our study is less than in most other studies ( table 1 ) [4, 8, 9, 11, 12, 15, 16] . This may be due to differences in the classification of genetic disorders, population demographics and the mode of data collection.
Classification of Disorders. Our study identified only single gene and chromosomal disorders while most others identified all disorders with a genetic component, often divided into subgroups. Thus, our sample was more stringently defined than others, which may partly account for our lower estimates. For example, although Yoon et al. [16] limited their dataset to mainly single gene and chromosomal disorders, they also included all birth defects, including those of multi-factorial and non-genetic origin (e.g. cleft lip and palate, fetal alcohol syndrome). However, by limiting our analyses to single gene and chromosomal disorders we have provided information about a subgroup of potentially severe disorders to enable improved health service planning for those affected.
Population Differences. Most published studies have been based in Northern [4, 7-9, 11, 14] and Latin [6, 13] America, and the ethnicity of these populations is very different from WA. For example, Kumar et al. [9] reported on a predominantly Hispanic and African American population in New York while Yoon et al. [16] reported that 40% of admissions in South Carolina were of African American patients. This is reflected in the frequency of admissions due to specific conditions. For example, sickle cell diseases accounted for 27% of genetic admissions in South Carolina, compared to 1.3% of admissions due to single gene and chromosomal disorders in WA.
Mode of Data Collection. Most studies investigating the impact of genetic disease have done so via direct review of medical records in 1 or 2 hospitals, with only this study, Yoon et al. [16] and Baird et al. [29] accessing statewide data. Studies that used direct review may get more complete ascertainment of admissions due to single gene and chromosomal disorders for a number of reasons. Firstly, the hospitals surveyed tended to be located in large cities and are often referral centers for their region. Thus, clinicians in these hospitals may have greater exposure to and expertise at diagnosing genetic disorders compared to clinicians practicing in smaller local hospitals. As 26% of the WA population lives in rural or remote areas [19] it is possible that some children and adolescents with single gene or chromosomal disorders may not be correctly diagnosed unless they receive medical attention from a metropolitan tertiary hospital. Thus, our use of a statewide database reporting all admissions in WA between 2000 and 2006 may have led to a lower estimates of patients, admissions and hospital costs associated with single gene and chromosomal disorders compared to a record review of a tertiary hospital. Secondly, others have reported that using ICD codes to extract data from hospital morbidity records leads to an underestimation of up to 25% of the true impact of genetic disease compared to using the same ICD-10 codes in a manual review [11] .
However, the direct review of hospital records is timeand labor-intensive and studies are limited to 1 or 2 children's hospitals, whilst a population database approach reflects the entire population over time rather than specialized services or short-term trends. Thus, the 2 approaches are complementary and both add valuable information.
Conclusion
This paper provides the first description of the impact of single gene and chromosomal disorders on hospital services in Australia. We believe the Western Australian hospital morbidity database is a valuable resource for obtaining information about the impact of single gene and chromosomal disorders on hospital admissions, although it may provide a relatively conservative estimate, based on comparison with international studies. Data generated by this study will act as baseline data for future studies investigating the impact of genetic disease in WA and inform planning of hospital services, genetic testing, screening and counseling services, and genetic education for health professionals.
